Chester County News and Community Website
NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) reported its financial results for the year ended December 31, 2025, and outlined progress across its antiviral pipeline, alongside a private financing …
Traws Pharma Reports 2025 Results, Secures Up to $60M Financing Read More
WILMINGTON, DE — Phreesia Inc. (NYSE: PHR) reported a profit for its fiscal fourth quarter and full year ended January 31, 2026, while lowering its revenue outlook for fiscal 2027 …
Phreesia Reports Q4 Profit, Lowers Fiscal 2027 Revenue Outlook Read More
WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW; OTC: ONFOP) reported full-year 2025 financial results showing increased revenue and improved operating metrics, the company said in its annual filing …
Onfolio Reports 2025 Results With Revenue Growth, Narrower Loss Read More
WAYNE, PA — Palvella Therapeutics, Inc. (Nasdaq: PVLA) recently reported its full-year 2025 financial results and outlined progress across its QTORIN drug development pipeline, including plans to submit a new …
Palvella Reports 2025 Results, Advances QTORIN Drug Pipeline Read More
NEWTOWN, PA — Solana Company (Nasdaq: HSDT) recenlty reported fourth-quarter net income of $325.6 million for 2025, driven by gains on derivative liabilities, while posting a full-year net loss of …
Solana Company Reports Q4 Profit Amid Digital Asset Volatility Read More
PHILADELPHIA, PA — Cabaletta Bio Inc. (Nasdaq: CABA) recently reported fourth-quarter and full-year 2025 results and said it is advancing clinical development of its rese-cel cell therapy program for autoimmune …
Cabaletta Reports Results, Advances Rese-Cel Autoimmune Program Read More
WARMINSTER, PA — Arbutus Biopharma Corporation (Nasdaq: ABUS) recently reported its fourth-quarter and full-year 2025 results and disclosed a global settlement with Moderna valued at up to $2.25 billion, the …
Arbutus Reports Results, Announces $2.25B Moderna Settlement Read More
LANGHORNE, PA — TEN Holdings Inc. (Nasdaq: XHLD) reported a decline in revenue and a wider net loss for fiscal year 2025 as the company incurred higher expenses tied to …
TEN Holdings Reports 2025 Revenue Decline, Wider Net Loss Read More
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) reported fourth-quarter and full-year 2025 financial results while advancing its lead candidate nomlabofusp toward a planned FDA filing for the treatment …
Larimar Reports Results, Advances Nomlabofusp Toward FDA Filing Read More
PHILADELPHIA, PA — Five Below, Inc. (Nasdaq: FIVE) reported higher net sales and earnings for the fourth quarter and full year of fiscal 2025, driven by comparable sales growth and …
Five Below Reports Q4, Full-Year 2025 Sales and Earnings Growth Read More